Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients.

Kato, Shingo; Horita, Nobuyuki; Utsunomiya, Daisuke

Kato, Shingo; Horita, Nobuyuki; Utsunomiya, Daisuke.

Kato S; Department of Diagnostic Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Kanagawa, Japan; Department of Cardiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan.
Horita N; Chemotherapy Center, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Utsunomiya D; Department of Diagnostic Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Kanagawa, Japan.

Am J Cardiol ; 172: 159-161, 2022 06 01.

Article in English | MEDLINE | ID: covidwho-1838525

Subject(s)

COVID-19; Myocarditis; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Incidence; Male; Myocarditis/epidemiology; Myocarditis/etiology; RNA, Messenger; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Observational study Topics: Vaccines Limits: Humans / Male Language: English Journal: Am J Cardiol Year: 2022 Document Type: Article Affiliation country: J.amjcard.2022.02.010

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google